[Beyond the psychometric assessments: the evaluation of patients with Alzheimer's disease].

نویسندگان

  • Wen-Fu Wang
  • Chuan-Ju Wang
  • Yao-Ting Huang
چکیده

Alzheimer's disease is a neurodegenerative illness. The Mini Mental State Examination (MMSE), Cognitive Abilities Screening Instrument (CASI) and Clinical Dementia Rating (CDR) are applied to assess whether a person suffers Alzheimer's disease and determine its severity. There are many confounding factors within those assessments, medical professionals need to bear in mind the pitfalls when evaluating the data and the patient.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of Visual Signs and Symptoms in Patients with Alzheimer's Disease

Background and Objective:Patients with Alzheimer's disease have impaired visual function even in the early stages of the disease. Therefore, the present study aimed to determine the visual signs and symptoms in patients with Alzheimer's disease and compare them with those in the control group. Materials and Methods:This cross-sectional descriptive study was conducted on 19 Alzheimer patients a...

متن کامل

Psychometric Evaluation of Patients with Behçet's Disease

Behçet’s disease is a vasculitis with multi-organ involvement. Our knowledge of the psychological aspects of Behçet’s disease is very limited. 40 women and 24 men who fulfilled the International Study Group (ISG) criteria of Behçet’s disease were selected from Behçet’s Disease Clinic of Nemazee Hospital Shiraz, South of Iran. Controls consisted of 65 healthy volunteers. Both patients and contro...

متن کامل

The diagnostic difference between 18F- FDG PET and 99mTc-HMPAO SPECT perfusion imaging in assessment of Alzheimer's disease

Introduction:Brain imaging with F-18 fluorodeoxyglucose (18F-FDG) positron ‎emission tomography or Tc-99m hexamethylpropyleneamine oxime (‎99mTc-HMPAO) SPECT is widely used for the evaluation of Alzheimer's ‎dementia (AD); we aim to assess superiority of one method over the ‎other. Methods: Twenty four patients with clinical diagnosi...

متن کامل

The recent development in synthesis and pharmacological evaluation of small molecule to treat Alzheimer's diseases: A review

Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A neurodegenerative type of dementia, the disease starts mild and gets progressively worse. Like all types of dementia, Alzheimer's is caused by brain cell death. The most common presentation marking Alzheimer's dementia is where symptoms of memory loss are the most promine...

متن کامل

The recent development in synthesis and pharmacological evaluation of small molecule to treat Alzheimer's diseases: A review

Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A neurodegenerative type of dementia, the disease starts mild and gets progressively worse. Like all types of dementia, Alzheimer's is caused by brain cell death. The most common presentation marking Alzheimer's dementia is where symptoms of memory loss are the most promine...

متن کامل

ذخیره در منابع من

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Acta neurologica Taiwanica

دوره 19 1  شماره 

صفحات  -

تاریخ انتشار 2010